| Fusobacterium nucleatum and colorectal cancer: A review |
47 |
| Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review |
16 |
| Role of circular RNAs in gastric cancer: Recent advances and prospects |
14 |
| Effect of exercise on colorectal cancer prevention and treatment |
11 |
| Conversion surgery for gastric cancer patients: A review |
11 |
| Precision medicine in gastric cancer |
10 |
| Tumor progression-dependent angiogenesis in gastric cancer and its potential application |
10 |
| Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery |
10 |
| Sessile serrated adenoma detection rate is correlated with adenoma detection rate |
9 |
| Risk of gastric cancer development after eradication of Helicobacter pylori |
8 |
| Premalignant lesions and gastric cancer: Current understanding |
8 |
| AU-rich element-binding proteins in colorectal cancer |
8 |
| Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion in vitro |
8 |
| Deep learning with convolutional neural networks for identification of liver masses and hepatocellular carcinoma: A systematic review |
7 |
| Inflammation-associated microsatellite alterations: Mechanisms and significance in the prognosis of patients with colorectal cancer |
7 |
| Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection |
7 |
| Robotic total meso-rectal excision for rectal cancer: A systematic review following the publication of the ROLARR trial |
7 |
| Current strategies for malignant pedunculated colorectal polyps |
7 |
| Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma |
7 |
| Shattering the castle walls: Anti-stromal therapy for pancreatic cancer |
7 |
| Advancements and challenges in treating advanced gastric cancer in the West |
6 |
| Feasibility of terahertz imaging for discrimination of human hepatocellular carcinoma |
6 |
| Small intestinal hemangioma: Endoscopic or surgical intervention? A case report and review of literature |
6 |
| Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data |
6 |
| Prediction of malignancy and adverse outcome of solid pseudopapillary tumor of the pancreas |
6 |
| Qingjie Fuzheng granules inhibit colorectal cancer cell growth by the PI3K/AKT and ERK pathways |
6 |
| Sarcopenia in pancreatic cancer - effects on surgical outcomes and chemotherapy |
5 |
| Endothelial cells in colorectal cancer |
5 |
| Old vs new: Risk factors predicting early onset colorectal cancer |
5 |
| SFRP4 expression correlates with epithelial mesenchymal transition-linked genes and poor overall survival in colon cancer patients |
5 |
| Emerging role of long non-coding RNA in the development of gastric cancer |
5 |
| Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review |
5 |
| Targeted agents for second-line treatment of advanced hepatocellular carcinoma |
5 |
| Endoscopic management of esophageal cancer |
5 |
| Prognostic and pathological impact of tumor budding in gastric cancer: A systematic review and meta-analysis |
5 |
| Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer |
5 |
| Comparison of endoscopic submucosal dissection with surgical gastrectomy for early gastric cancer: An updated meta-analysis |
5 |
| Multicenter phase. trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer |
5 |
| Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy |
5 |
| Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma |
4 |
| Abnormally expressed circular RNAs as novel non-invasive biomarkers for hepatocellular carcinoma: A meta-analysis |
4 |
| Current status of adjuvant chemotherapy for gastric cancer |
4 |
| Ampulla of Vater carcinoma: Molecular landscape and clinical implications |
4 |
| Laparoscopic and endoscopic cooperative surgery for gastric tumors: Perspective for actual practice and oncological benefits |
4 |
| Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer |
4 |
| Clutch Cutter knife efficacy in endoscopic submucosal dissection for early gastric neoplasms |
4 |
| Utilizing gastric cancer organoids to assess tumor biology and personalize medicine |
4 |
| Efficacy of hybrid minimally invasive esophagectomy vs open esophagectomy for esophageal cancer: A meta-analysis |
4 |
| TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer |
3 |
| Non-coding RNA in drug resistance of gastric cancer |
3 |
